Epidermal Growth Factor Receptor as a Target for Anti-Cancer Agent Design

E-ISSN： 1875-5992|10|6|491-503

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.10, Iss.6, 2010-07, pp. : 491-503

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of an Anti-epidermal Growth Factor Receptor in Treating Cancer

By Waksal H.W.

Cancer and Metastasis Reviews, Vol. 18, Iss. 4, 1999-12 ,pp. : 427-436

Springer Publishing Company

Access to resources Recommend Favorite

Anti-Epidermal Growth Factor Receptor Strategies for Advanced Breast Cancer

By Campos Susana

Cancer Investigation, Vol. 26, Iss. 8, 2008-10 ,pp. : 757-768

Informa Healthcare

Access to resources Recommend Favorite

Anti-Epidermal Growth Factor Receptor Antibodies in the Treatment of Metastatic Colorectal Cancer

Recent Patents on Anti-Cancer Drug Discovery, Vol. 5, Iss. 2, 2010-06 ,pp. : 142-151

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of combination anti-vascular endothelial growth factor receptor and anti-epidermal growth factor receptor therapies on the growth of gastric cancer in a nude mouse model

By Jung Y.D. Mansfield P.F. Akagi M. Takeda A. Liu W. Bucana C.D. Hicklin D.J. Ellis L.M.

European Journal of Cancer, Vol. 38, Iss. 8, 2002-05 ,pp. : 1133-1140

Elsevier

Access to resources Recommend Favorite

Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs

By Ciardiello F. Tortora G.

European Journal of Cancer, Vol. 39, Iss. 10, 2003-07 ,pp. : 1348-1354

Elsevier

Access to resources Recommend Favorite